EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy

Monalyn Marabi iD, Yuyang Li, Chaiwat Aphivatanasiri iD, Julia Y Tsang iD, Joshua Jx Li iD, Lin-Ying Chen iD, Gary M Tse iD

Histopathology · 2026

DOI: 10.1111/his.70143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Monalyn Marabi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University …. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Lymphocytes, Tumor-Infiltrating, Calcinosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: cheng yue pui charity foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

De‐escalated treatment for ductal carcinoma in situ (DCIS) aims to prevent overtreatment of patients. However, patients diagnosed preoperatively with pure DCIS via core needle biopsy (CNB) may be upgraded to invasive cancer upon excision. Therefore, it is essential to stratify patients at low risk for upgrade to invasive disease during the biopsy to inform management decisions. Methods and results In this study, we reviewed a cohort of patients with pure DCIS diagnosed by CNB and their corresponding excision specimens to identify predictive features for upgrading to microinvasion or invasive breast cancer (IBC). Of the 228 CNB cases, 82 (36%) were upgraded at excision, with 26.8% classified as microinvasion and 73.2% as frank invasion. Significant tumour intrinsic features associated with DCIS upgrade included larger tumour size, palpable mass, high grade and presence of necrosis ( P ≤ 0.026). Factors related to sampling adequacy, such as the number of cores, total core length and length of the longest core, were also predictive features ( P ≤ 0.027). Additionally, tumour microenvironment (TME) characteristics, including calcification and stromal tumour‐infiltrating lymphocytes (sTIL), were linked to upgrades, particularly in the human epidermal growth factor 2 (HER2)‐negative subgroup ( P ≤ 0.004). These features were independently associated with frank invasion in HER2‐negative cancers.

Conclusions

Our results provide valuable insights into additional predictive features for DCIS upgrade. When combined with adequate sampling and intrinsic tumour characteristics, TME features—namely tumour infiltrating lymphocytes (TILs) and calcification—are useful in predicting DCIS upgrades, especially in HER2‐negative cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingLymphocytes, Tumor-InfiltratingCalcinosisHumansFemaleBiopsy, Large-Core NeedleMiddle AgedErb-b2 Receptor Tyrosine KinasesAgedAdultTumor MicroenvironmentBiomarkers, TumorAged, 80 and over

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
  • Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
  • Department of Pathology, School of Clinical Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong.

ORCID-Profile: Monalyn Marabi, Chaiwat Aphivatanasiri, Julia Y Tsang, Joshua Jx Li, Lin-Ying Chen, Gary M Tse

Förderung

  • cheng yue pui charity foundation

Zitieren

APA

Marabi, M., Li, Y., Aphivatanasiri, C., Tsang, J. Y., Li, J. J., Chen, L. Y., & Tse, G. M. (2026). Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy. Histopathology. https://doi.org/10.1111/his.70143

Vancouver

Marabi M, Li Y, Aphivatanasiri C, Tsang JY, Li JJ, Chen LY, et al. Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy. Histopathology. 2026. doi:10.1111/his.70143

BibTeX
@article{Marabi2026,
  author = {Marabi, Monalyn and Li, Yuyang and Aphivatanasiri, Chaiwat and Tsang, Julia Y and Li, Joshua Jx and Chen, Lin-Ying and Tse, Gary M},
  title = {Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70143}
}
Kostenlos starten →